Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, N.
Right arrow Articles by Yamamoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, N.
Right arrow Articles by Yamamoto, N.
Related Collections
Right arrow Gene Expression
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 April 2001, Vol. 97, No. 7, pp. 2137-2144

NEOPLASIA

Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta  signaling through interaction with CREB-binding protein/p300

Naoki Mori, Mariko Morishita, Tomoo Tsukazaki, Chou-Zen Giam, Atsushi Kumatori, Yuetsu Tanaka, and Naoki Yamamoto

From the Department of Preventive Medicine and AIDS Research and the Department of Biochemistry, Institute of Tropical Medicine, Nagasaki University; the Departments of Anatomy and Surgery II, Nagasaki University School of Medicine, Japan; the Department of Infectious Disease and Immunology, Okinawa-Asia Research Center of Medical Science, Faculty of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan; and the Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD.

Human T-cell leukemia virus type I (HTLV-I) Tax is a potent transcriptional regulator that can activate or repress specific cellular genes and that has been proposed to contribute to leukemogenesis in adult T-cell leukemia. Previously, HTLV-I- infected T-cell clones were found to be resistant to growth inhibition by transforming growth factor (TGF)-beta . Here it is shown that Tax can perturb Smad-dependent TGF-beta signaling even though no direct interaction of Tax and Smad proteins could be detected. Importantly, a mutant Tax of CREB-binding protein (CBP)/p300 binding site, could not repress the Smad transactivation function, suggesting that the CBP/p300 binding domain of Tax is essential for the suppression of Smad function. Because both Tax and Smad are known to interact with CBP/p300 for the potentiation of their transcriptional activities, the effect of CBP/p300 on suppression of Smad-mediated transactivation by Tax was examined. Overexpression of CBP/p300 reversed Tax-mediated inhibition of Smad transactivation. Furthermore, Smad could repress Tax transcriptional activation, indicating reciprocal repression between Tax and Smad. These results suggest that Tax interferes with the recruitment of CBP/p300 into transcription initiation complexes on TGF-beta -responsive elements through its binding to CBP/p300. The novel function of Tax as a repressor of TGF-beta signaling may contribute to HTLV-I leukemogenesis.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. Grant, U. Oh, K. Yao, Y. Yamano, and S. Jacobson
Dysregulation of TGF-{beta} signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease
Blood, June 15, 2008; 111(12): 5601 - 5609.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. L. Di Bartolo, M. Cannon, Y.-F. Liu, R. Renne, A. Chadburn, C. Boshoff, and E. Cesarman
KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor
Blood, May 1, 2008; 111(9): 4731 - 4740.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Datta, M. Bellon, U. Sinha-Datta, A. Bazarbachi, Y. Lepelletier, D. Canioni, T. A. Waldmann, O. Hermine, and C. Nicot
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Blood, August 1, 2006; 108(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Dong and G. C. Blobe
Role of transforming growth factor-beta in hematologic malignancies
Blood, June 15, 2006; 107(12): 4589 - 4596.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Tabakin-Fix, I. Azran, Y. Schavinky-Khrapunsky, O. Levy, and M. Aboud
Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications
Carcinogenesis, April 1, 2006; 27(4): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. S. Jones, S. Akel, C. Petrow-Sadowski, Y. Huang, D. C. Bertolette, and F. W. Ruscetti
Induction of Human T Cell Leukemia Virus Type I Receptors on Quiescent Naive T Lymphocytes by TGF-{beta}
J. Immunol., April 1, 2005; 174(7): 4262 - 4270.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yoshida, K. Nosaka, J.-i. Yasunaga, I. Nishikata, K. Morishita, and M. Matsuoka
Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells
Blood, April 1, 2004; 103(7): 2753 - 2760.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J.-C. Twizere, V. Kruys, L. Lefebvre, A. Vanderplasschen, D. Collete, C. Debacq, W. S. Lai, J.-C. Jauniaux, L. R. Bernstein, O. J. Semmes, et al.
Interaction of Retroviral Tax Oncoproteins With Tristetraprolin and Regulation of Tumor Necrosis Factor-{alpha} Expression
J Natl Cancer Inst, December 17, 2003; 95(24): 1846 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Sasaki, H. Suzuki, K. Yagi, M. Furuhashi, R. Yao, S. Susa, T. Noda, Y. Arai, K. Miyazono, and M. Kato
Lymphoid Enhancer Factor 1 Makes Cells Resistant to Transforming Growth Factor {beta}-induced Repression of c-myc
Cancer Res., February 15, 2003; 63(4): 801 - 806.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Arnulf, A. Villemain, C. Nicot, E. Mordelet, P. Charneau, J. Kersual, Y. Zermati, A. Mauviel, A. Bazarbachi, and O. Hermine
Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis
Blood, December 1, 2002; 100(12): 4129 - 4138.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. K. Lee, B.-C. Kim, J. N. Brady, K.-T. Jeang, and S.-J. Kim
Human T-cell Lymphotropic Virus Type 1 Tax Inhibits Transforming Growth Factor-beta Signaling by Blocking the Association of Smad Proteins with Smad-binding Element
J. Biol. Chem., September 6, 2002; 277(37): 33766 - 33775.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020